Company Analysis

Phio Pharmaceuticals Corp. (PHIO)

Nasdaq: PHIO · Pharmaceutical Preparations · King Of Prussia, PA · filing with the SEC since 2011
Grade4.0
◀ Past 1.3● Present 4.6▶ Future 5.2
4 est.

Who owns Phio Pharmaceuticals Corp.

As filed with the SEC
Holders of 5% or more
2
CVI Investments, Inc. holds 9.9% of Common Stock, $0.0001 par value per share, as its SCHEDULE 13G/A filed Feb 17, 2026 says.
Directors and officers
8
report now, of 17 people on the record since 2013. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
CVI Investments, Inc.
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, $0.0001 par value per share · 9.9% in Nov 10, 2025
9.9%
Mitchell P. Kopin
SCHEDULE 13G/A · filed Feb 13, 2026 · Common stock, par value $0.0001 per share · 7% in Nov 7, 2025
9.1%
Orca Capital AG
SCHEDULE 13G/A · filed Dec 11, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 6.5% in Nov 24, 2025
under 5%
What PHIO reports owning in othersstakes of 5% or more, and other ties
Phio Pharmaceuticals Corp. reports no stake in another company in the record.
Insider tradesForm 4
0sales
16purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
1720212223242526
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 17 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Bitterman Robert JChairman, Pres. & CEO0$008$100,000
Plott Ronald Todddirector0$004$0
Deming David Hdirector0$002$0
Bradford Patricia Adirector0$002$0
SI Assistanton PHIO · research, not advice